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ABSTRACT 
The retina is the most oxygen consuming tissue of the body. Rod and cone photoreceptors efficiently carry 
out visual cascades, which are energetically costly processes. Data has recently been published that 
suggests that the metabolic support to phototransduction in the rod outer segment (OS) may originate 
directly in the OS, which is able to conduct aerobic metabolism. This oxygen-handling activity of the rod OS, 
which was never suspected before, appears to be a primary cause of the generation of reactive oxygen 
species directly inside the OS. Oxidative stress has been hypothesised to contribute to most of the 
neurodegenerative retinal pathologies, such as diabetic retinopathy, age-related macular degeneration, 
retinitis pigmentosa and photoreceptor cell death after retinal detachment. Many natural antioxidant 
compounds are routinely used in experimental or human therapies for preventing or delaying 
photoreceptor degeneration in those pathologies. Here it is proposed that the ultimate reason for the 
beneficial actions of antioxidants in preventing or retarding the effect on the retinal degenerative 
pathologies can be found in their action on reactive oxygen species generated by the ectopic mitochondrial 
electron transport chain (ETC) coupled to FoF1-ATP synthase in rod OS disks. In fact, if not adequately 
coupled, the ETC generates reactive oxygen species that, in turn, can act on the polyunsaturated fatty acids 
which the rod OS is rich in. If correct, the mechanism put forward here would provide a potential for the 
molecular basis of therapies with antioxidants for retinal degenerative diseases.  
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INTRODUCTION  
The vertebrate retina contains two types of photoreceptors, 
rods and cones, which carry out the first step of vision. Both 
possess a specialised compartment: the outer segment (OS) 
that is dedicated to phototransduction, and the inner segment 
(IS), which contains the subcellular organelles and nucleus. The 
retina is particularly susceptible to oxidative stress because of 
its high O2 consumption [1], its high proportion of 
polyunsaturated fatty acids [2, 3], and its exposure to visible 
light. Considering the limited understanding of the origin of the 
ATP supply in OS [4-6], where continual ATP consumption is 
observed particularly during light adaptation, a high cGMP flux 
rate is observed [7] (i.e. a higher steady PDE activity). In 
addition, there is a correspondingly higher activity of guanylate 
cyclase, the enzyme that synthesises cyclic GMP from GTP. 
Moreover, it was shown that visual transduction is supported 
by oxidative metabolism [8], and that anaerobic glycolysis is not 
sufficient to provide enough ATP in the light. This group has 
conducted proteomic analysis of purified OS disks and reported 
[9] that these express most of the subunits of the mitochondrial 
machinery for oxidative phosphorylation, such as Kreb’s cycle 
enzymes and electron transport chain (ETC) proteins, as well as 
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FoF1-ATP synthase. The ETC complexes are composed of NADH 
dehydrogenase (ETC I), succinate dehydrogenase (ETC II), 
ubiquinol-cytochrome c oxidoreductase (ETC III), cytochrome c, 
cytochrome c oxidase (ETC IV) and F1Fo-ATP synthase (V), 
performing the oxidative phosphorylation that is currently 
believed to be exclusive to the mitochondrial membrane in 
eukaryotes. Rod disks possess active respiratory complexes that 
may build up a proton gradient also in vivo, which the ectopic 
ATP synthase can utilise to aerobically synthesise ATP outside 
the mitochondrion. The OS would supply chemical energy for 
phototransduction through extra-mitochondrial aerobic ATP 
synthesis [4, 9-11]. Similar results were obtained on intact 
myelin vesicles [12-14] and C6 glioma cell plasma membranes 
[15]. The activity of the Tricarboxylic Acid (TCA) cycle enzymes 
was also reported to be consistent in the rod OS [11] , which is 
in keeping with the knowledge that  many mitochondrial 
proteins possess dual or multiple localisations, [16] and that 
mitochondria are dynamic organelles [17]. While the 
mitochondrial proteome consists of more than 1,000 different 
proteins, many proteomic analyses of cellular membranes have 
found the exclusive expression of proteins from the five 
respiratory complexes [18]. Therefore, a large proportion of the 
high retinal rate of  O2 consumption would depend on the rod 
OS, justifying the phenomenon of rod-induced hypoxia on a 
quantitative basis [6]. Taking into consideration the existence of 
O2 consumption in the rod OS, a hypothesis for the 
involvement of oxidative stress in the pathogenic mechanism 
for many acquired and inherited retinal degenerations has been 
recently proposed [6]. Moreover, a decline in the rod OS ETC 
functioning, along with an increase in reactive oxygen species 
production and the consequent chronic oxidative stress, would 
generate hypometabolism, in turn causing an imbalance in the 
clearance of proteins. This may cause the aggregation of 
peptides and the generation of drusen [6]. The ETC embedded 
in the disk membranes would be a primary source of 
superoxides [19]. Reactive oxygen species are in fact by-
products of ETC functioning, and their overproduction is 
foreseen in any pathological condition that uncouples ATP 
synthase from the ETC.  
Oxidative stress has been implicated in the development of 
diabetic retinopathy, and has also been shown to be a risk 
factor for age-related macular degeneration (AMD) [20-  and 
retinitis pigmentosa (RP) [24-26], which are the most common 
degenerative diseases of the retina. It was also shown to play a 
fundamental role in photoreceptor cell death after retinal 
detachment (RD) [27]. Moreover, extensive research suggests 
that, in those retinal pathologies, naturally occurring 
compounds with antioxidant actions, that are components of a 
normal diet, are greatly beneficial. Several studies showed that 
antioxidants appeared to retard or inhibit the degenerative 
pathology [28-30]. Interestingly, curcumin, anthocianins and 
cathechins are inhibitors of ATP synthase [31]. 
HYPOTHESES 
Considering the aforementioned facts, the present paper 
hypothesises that the reason for the efficacy of antioxidants in 
preventing or retarding the onset of many retinal degenerative 
pathologies in both experimental and clinical studies is a result 
of their scavenging action on reactive oxygen species produced 
inside the OS. These species can be generated by the 
ectopically-expressed mitochondrial ETC that is coupled to ATP 
synthase in rod OS disks. In fact, it is quite doubtful that 
antioxidants can scavenge reactive oxygen species inside the 
mitochondrion, as they have been found to be unable to 
penetrate mitochondria [31]. 
DISCUSSION 
Oxidative stress is also implicated in the development of 
diabetic complications, in particular diabetic retinopathy [32]. 
Moreover, the antioxidant mechanisms are impaired in diabetic 
conditions [33-35]. The administration of antioxidants to 
diabetic rats prevents oxidative damage in the retina and the 
development of retinopathy [36]. Lutein prevented the 
impairment of the electroretinogram observed in controls [37]. 
The antioxidant lutein, a dietary carotenoid, was also shown to 
be useful in AMD [28]. The Eye Disease Case-Control Study 
found that high plasma levels of lutein and zeaxanthin are 
associated with a reduced risk of neovascular AMD [38, 39]. 
 Oxidative stress plays an important role in photoreceptor cell 
death after RD. Treatment with a reactive oxygen species 
scavenger (e.g. Edaravone) was shown to  prevent 
photoreceptor cell death after RD [27]. The model of oxidative 
stress in photoreceptor cell death after RD is interesting as it 
rules out a role for retinal pigmented epithelium. Oxidative 
stress may also act as a mediator of retinal degeneration in RP, 
and is, in fact, believed to play an important role in 
photoreceptor cell death [40, 41]. Increased lutein dietary 
intake increases macular pigment optical density, improving 
visual function [42]. Anthocyanins are known to be effective 
ingredients for maintaining eye health, as they are potent 
antioxidants that have been shown to exert a role against lipid 
peroxidation [43] and to protect against retinal damage [44, 
45]. Extensive research suggests that pro-anthocyanins are 
beneficial to health in general, especially in improving vision, 
because of their antioxidant effects [46]. Anthocyanin-rich 
bilberry extract prevented the impairment of photoreceptor 
cell function, as measured by electroretinogram, in a mouse 
model of endotoxin-induced uveitis [47]. Catechins, and EGCG 
in particular, act as biological antioxidants [48], which are able 
to scavenge superoxide, hydroxyl radicals, singlet oxygen and 
peroxynitrite [46, 48]. Curcumin (1,7-bis(4-hydroxy-3-
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methoxyphenyl)1,6-heptadiene-3,5-dione), which is a principal 
component of turmeric, is a promising candidate for the rescue 
of retinal ischemic diseases [31, 49]. Curcumin is well known for 
its anti-tumour, antioxidant, and anti-inflammatory properties. 
Its anti-protein aggregating activity was examined in particular 
studies on rats expressing the P23H rhodopsin (Rh) mutation, 
and it rescued photoreceptors from degeneration due to the 
toxicity of Rh aggregates [49].  
Oxidative stress, i.e. the cellular damage caused by reactive 
oxygen species (free radicals, superoxide, hydrogen peroxide, 
and singlet oxygen), has been hypothesised to contribute to the 
development of AMD [23, 39], and diabetic retinopathy [28, 
50], which are among the most common cause of blindness in 
the United States. The retina is considered to be particularly 
susceptible to oxidative stress, and the contribution of the rod 
OS should be considered [6] because of its unexpected O2 
consumption ability [1], and the high proportion of 
polyunsaturated fatty acids in the disk membranes [2], which 
are highly enriched in docosahexaenoic acid (DHA). DHA is 
prone to peroxidation, one of the major events induced by 
oxidative stress, particularly in polyunsaturated fatty acid-rich 
biomembranes. The photoreceptor OS contain the highest 
concentration of polyunsaturated fatty acids of any vertebrate 
tissue, and, in fact, is considered a model for the study of lipid 
peroxidation [3]. Furthermore, there is strong evidence 
suggesting that lipofuscin, which is produced during oxidative 
damage and is a photo-reactive substance, is found in the 
photoreceptor OS as a consequence of oxidative stress [51]. It 
was also shown that complex I in particular is the major 
complex responsible for the generation of reactive oxygen 
species [19]. In turn, disk membrane lipid peroxidation would 
be associated with impairment of the protein functions therein 
located, in particular the ETC, which are extremely sensitive to 
the state of the membrane environment. Moreover, the 
disruption of cytochromes might free iron, thereby generating 
dangerous redox reactions.  
CONCLUSION 
The extensive literature data on the protective role of 
antioxidants utilised in many pharmaceutical preparations for 
humans, on photoreceptor degeneration, as well as several 
reports of a pivotal role of oxidative stress in the pathogenesis 
of degenerating retinal diseases, is suggestive of a role of 
oxygen radicals on the OS itself. This appears easier to 
understand when considering the expression of a functional 
ETC in OS disks, which is an efficient but dangerous location for 
O2 utilisation, especially considering the presence of 
polyunsaturated fatty acids.  
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